Physician profile
Amy Merrill
NPI 1558726935
$357.17
in general payments reported to CMS, 2019-2025
10 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.42 · 2023: $14.48 · 2024: $14.66 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $77.25 | 2024-2025 | |
| Axsome Therapeutics, INC. | $56.21 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $46.53 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.98 | 2025 | Jardiance |
| Novo Nordisk INC | $35.80 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.29 | 2025 | Caplyta |
| Amgen INC. | $19.42 | 2021 | |
| Lilly USA, LLC | $18.66 | 2025 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $17.65 | 2025 | Gemtesa |
| Valinor Pharma, LLC | $14.38 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Merrill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.